Home

Immunität eine Erkältung bekommen Der Pfad gvp module vii emotional erben wählen

Eu module VII: PSUR released for public consultation
Eu module VII: PSUR released for public consultation

Renewals | Dr. Ebeling & Assoc. GmbH
Renewals | Dr. Ebeling & Assoc. GmbH

Eu module VII: PSUR released for public consultation
Eu module VII: PSUR released for public consultation

Guideline on good pharmacovigilance practices (GVP)
Guideline on good pharmacovigilance practices (GVP)

Kurs: GVP Module I und II PV-System und Qualitätssysteme, PSMF - Springest
Kurs: GVP Module I und II PV-System und Qualitätssysteme, PSMF - Springest

Eu module VII: PSUR released for public consultation
Eu module VII: PSUR released for public consultation

Europe - Guideline on Good Pharmacovigilance Practices (GVP) Module VII -  Explanatory Note - RIS.WORLD
Europe - Guideline on Good Pharmacovigilance Practices (GVP) Module VII - Explanatory Note - RIS.WORLD

Eu2P Short Course: GVP Module VII - Periodic Safety Update Report (PSUR)
Eu2P Short Course: GVP Module VII - Periodic Safety Update Report (PSUR)

Europäische Patientenakademie zu Therapeutischen Innovationen Aspekte der  Pharmakovigilanz: Regelmäßige aktualisierte Sicherheitsberichte (PSURs) -  ppt herunterladen
Europäische Patientenakademie zu Therapeutischen Innovationen Aspekte der Pharmakovigilanz: Regelmäßige aktualisierte Sicherheitsberichte (PSURs) - ppt herunterladen

Explanatory Note to GVP - update Feb 2021
Explanatory Note to GVP - update Feb 2021

Commonalities-Periodic Benefit-Risk Evaluation Report (PBRER) and Risk  Management Plan (RMP).
Commonalities-Periodic Benefit-Risk Evaluation Report (PBRER) and Risk Management Plan (RMP).

PSURs | Dr. Ebeling & Assoc. GmbH
PSURs | Dr. Ebeling & Assoc. GmbH

Eu module VII: PSUR released for public consultation
Eu module VII: PSUR released for public consultation

Guideline on good pharmacovigilance practices (GVP) - Module VI –  Management and reporting of adverse reactions to medicinal p
Guideline on good pharmacovigilance practices (GVP) - Module VI – Management and reporting of adverse reactions to medicinal p

PharmaSupport: Pharmakovigilanz
PharmaSupport: Pharmakovigilanz

Discussion and feedback on Module VII: Periodic Safety Update Reports -  YouTube
Discussion and feedback on Module VII: Periodic Safety Update Reports - YouTube

MU103_10_002d_WL Wegleitung PSUR PBRER Information Einreichung HMV4
MU103_10_002d_WL Wegleitung PSUR PBRER Information Einreichung HMV4

Strategic Medical Writing in the Post-Authorisation Phase - Trilogy Writing  & Consulting GmbH
Strategic Medical Writing in the Post-Authorisation Phase - Trilogy Writing & Consulting GmbH

EMWA Winter 2021.qxp_Winter 2021
EMWA Winter 2021.qxp_Winter 2021

Eu module VII: PSUR released for public consultation
Eu module VII: PSUR released for public consultation

6b. BPI-Leitfaden zum Umgang mit Signalen – Pharma Kodex
6b. BPI-Leitfaden zum Umgang mit Signalen – Pharma Kodex

14 - Ludwig, Grossmann, Lustenberger - 01 - Workshop_DACH_V3_160307
14 - Ludwig, Grossmann, Lustenberger - 01 - Workshop_DACH_V3_160307

Pharmakovigilanz z
Pharmakovigilanz z